Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving borte- zomib-based therapy for multiple myeloma. (Record no. 28201712)

MARC details
000 -LEADER
fixed length control field 01387 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517205257.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201810s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1875-8592
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3233/CBM-170795
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Zhou, Xin
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20181001
245 00 - TITLE STATEMENT
Title Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving borte- zomib-based therapy for multiple myeloma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer biomarkers : section A of Disease markers
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 43-48 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bortezomib
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphocytes
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multiple Myeloma
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neutrophils
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wang, Jing
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Xia, Jun
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cheng, Feng
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mao, Jingjue
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhu, Jianwei
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Guo, Hongfeng
773 0# - HOST ITEM ENTRY
Title Cancer biomarkers : section A of Disease markers
Related parts vol. 22
-- no. 1
-- p. 43-48
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3233/CBM-170795">https://doi.org/10.3233/CBM-170795</a>
Public note Available from publisher's website

No items available.